FDA/CDC Archives - Page 15 of 17

News
FDA attacks antibiotic resistance with new strategy
September 14, 2018
Four-pronged approach addresses product development, stewardship, surveillance, and science.
News
CDC: 2017 worst year yet for drug overdoses
August 17, 2018
Deaths tied to synthetic opioids climbed faster than any other drug class.
News
Fluoroquinolones can cause fatal hypoglycemia, FDA warns
July 11, 2018
The FDA is strengthening warning labels on fluoroquinolones to reflect the risk of life-threatening hypoglycemia and neuropsychiatric adverse events.
News
CDC warns of hepatitis A outbreaks in injection drug users
June 11, 2018
Gap in vaccine availability now has been solved.
News
CDC concerned about multidrug-resistant Shigella
June 7, 2018
if clinicians need to use antibiotics to treat patients who have Shigella infections, they should monitor these patients carefully.
News
Zika topped Lyme in 2016
May 10, 2018
In the race between ticks and mosquitoes, who do you root for: Lyme or Zika?
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
May 4, 2018
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
News
Unusual antibiotic resistance found in more than 200 bacteria
April 4, 2018
Rare and unusual antibiotic resistance can be stamped out with aggressive prevention and control strategies.
News
FDA advisors recommend lofexidine for opioid withdrawal
March 27, 2018
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
Article
Opioid deaths in the ED increase nationally
March 6, 2018
Opioid overdose deaths have reached an all-time high across the country.